HB145 revises several provisions of Kentucky insurance law to clarify which health insurance statutes apply to which kinds of coverage. The bill amends KRS 304.17-020, creates a new section in Subtitle 17A of KRS Chapter 304, and amends KRS 304.18-010 to define the scope of the health insurance subtitles more precisely. In general, it states that the relevant subtitle provisions apply only to the individual market for health insurance unless a statute specifically says otherwise, and it adds a more detailed list of coverage types that are excluded from those subtitles.
The bill also expands and standardizes definitions used across the insurance code, including definitions of “health insurance,” “group health insurance,” “blanket health insurance,” “most recent effective date,” and “otherwise specifically indicated or provided.” It expressly excludes a wide range of products and arrangements from subtitle coverage, including accident-only, dental, vision, disability income, paid family leave, long-term care, Medicare supplement, hospital indemnity, fixed indemnity, limited health service plans, certain supplemental and gap-filling policies, public assistance or workers’ compensation-related coverage, on-site medical clinics, and health flexible spending arrangements. It also preserves the commissioner’s authority to identify additional similar or limited coverage types by regulation.
In practical terms, the bill would affect how Kentucky’s insurance statutes are interpreted and applied by insurers, regulators, and courts. It appears designed to reduce ambiguity about whether particular health-related products are subject to the individual, group, or blanket health insurance subtitles, and to prevent those subtitles from being read to cover products that are meant to function as supplemental, limited, or specialized coverage. The bill would not create a new insurance program or mandate coverage; rather, it reorganizes and narrows the statutory reach of existing insurance provisions.
Because there are no committee transcripts or recorded votes provided, the overall sentiment around HB145 cannot be measured from legislative debate or floor action. Based on the text alone, the bill appears technical and administrative in nature, with an emphasis on statutory clarification and conformity across related insurance subtitles. The lack of recorded opposition or support in the supplied materials suggests no documented controversy in the available record, though the breadth of the exclusions could matter to insurers, consumer advocates, and regulators who may differ on how broadly health insurance law should apply.
The main point of potential contention is the bill’s detailed list of exclusions and its reliance on commissioner rulemaking to identify additional “similar or limited” coverage types. Stakeholders concerned with consumer protections may view the narrowing language as limiting the reach of health insurance regulations, while insurers and industry groups may favor the clarity and reduced compliance uncertainty. The distinction between individual, group, and blanket market application may also be important for entities offering supplemental products, fixed indemnity coverage, or other nontraditional health-related benefits.
HB145 would amend Kentucky Revised Statutes Chapter 304 to clarify the scope of health insurance subtitles and to exclude specified categories of coverage from those subtitles unless a statute expressly says otherwise. It affects KRS 304.17-020, adds a new section to Subtitle 17A, and revises KRS 304.18-010, thereby influencing how insurers, the Department of Insurance, and courts interpret the applicability of health insurance regulations to individual, group, and blanket market products. The bill would primarily impact insurers offering supplemental, limited, or specialized health-related coverage, but it does not itself impose new coverage mandates or benefits.
No committee discussion or vote history was provided, so there is no direct evidence of support or opposition from legislative proceedings. From the bill text, the measure appears to be a technical clarification bill with a generally neutral or pragmatic policy posture, aimed at aligning statutory language and reducing ambiguity in insurance regulation. The absence of recorded controversy in the supplied materials suggests the bill may have been treated as a drafting or scope-clarification measure rather than a high-profile policy fight.
The most notable contention likely concerns the breadth of the exclusions and the extent to which the bill narrows the application of health insurance subtitles. Consumer advocates could object that excluding products such as fixed indemnity, supplemental gap coverage, or certain limited-benefit plans may reduce regulatory protections, while insurers may support the clearer boundaries and reduced compliance burden. Another possible point of debate is the commissioner’s authority to define additional excluded products by regulation, which gives administrative discretion over the statute’s reach.